Drug maker Pfizer has developed a drug called Aromasin.
A study has shown it can cut the risk of developing breast cancer by more than half in women who were post menopause.
They say the two drugs already on the market, Tamoxifen and Raloxifene , are unpopular because they can cause blood clots and uterine cancer.
The study of Aromasin showed none of those side effects.